Person

Sreelakshmi Kolli

Director, Zimmer Biomet

Current S&P 500 boards
2
Current roles
2
Open-market buys
$120K
Open-market sales
$7.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 30, 2023ZBHBuy1,000$120.37$120K
May 15, 2019ALGNSale1,123$327.13$367K
May 15, 2019ALGNSale743$327.31$243K
May 15, 2019ALGNSale780$327.44$255K
May 15, 2019ALGNSale1,159$328.27$380K
May 15, 2019ALGNSale264$327.16$86K
May 15, 2019ALGNSale1,136$327.39$372K
May 15, 2019ALGNSale1,466$326.80$479K
May 15, 2019ALGNSale1,621$326.29$529K
May 15, 2019ALGNSale1,187$327.51$389K
May 14, 2019ALGNSale10,016$321.53$3.2M
Nov 27, 2018ALGNSale4,000$222.96$892K
Nov 27, 2018ALGNSale1,000$223.92$224K
May 30, 2017ALGNSale1,000$144.00$144K

SEC reporting-owner ID (CIK) 1689392 · all filings on EDGAR